J.P. Morgan Sees Eli Lilly’s Incretin Portfolio Driving Revenue Past $135 Billion by 2030
J.P. Morgan raised its price target and earnings estimates for Eli Lilly, citing the drugmaker's incretin portfolio and pipeline. The…
Stock News
Latest stock market news — earnings reports, S&P 500, Nasdaq, major tech stocks and global equities. Expert analysis updated throughout the trading day.
Goldman: Tesla’s Cybercab Gives Cost Edge in Robotaxis, but Software Will Decide Scale
Goldman Sachs says Tesla's low-cost Cybercab could give the company a per-mile cost edge over robotaxi rivals, but the bank…
Anthropic’s $100 Billion AWS Commitment Faces Its First Financial Test in IPO Prospectus
Anthropic has committed more than $100 billion over ten years to Amazon Web Services, a deal already reflected in AWS's…
Cathie Wood’s ARK Invest Buys Robinhood Stock, Solana ETF Amid Jobs-Driven Market Selloff
Cathie Wood's ARK Invest bought 28,589 shares of Robinhood Markets and expanded its Solana ETF exposure on Sept. 4, even…
Nvidia’s ACIE Business Outgrows Hyperscalers as Data Center Revenue Tops Forecast
Nvidia's Data Center segment posted $89 billion in revenue last quarter, beating a $85.8 billion forecast, as its smaller ACIE…
